July 24, 2009

From The News Wire: UT Study Delays T1 Full Onset

UT researcher: interferon alpha can delay full onset of type I diabetes

HOUSTON – (July 1, 2009) – A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to researchers at The University of Texas Medical School at Houston.

The results of the Phase II trial are published today in Diabetes Care, a journal of the American Diabetes Association.

“It shows a strong trend in preserving insulin-producing beta cell function that is significantly better than placebo,” said Staley Brod, M.D., principal investigator of the trial, which includes the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “It can extend the ‘honeymoon phase’ of the disease, allowing the body to still produce insulin from beta cells, which correlates with decreased complication rates.”

http://publicaffairs.uth.tmc.edu/media/newsreleases/nr2009/type1diabetes.htm

No comments :

Post a Comment